Atypical Peripheral Hypertrophic Subepithelial Corneal Degeneration: A Rare Entity After Pterygium Excision
Published 2022 - 40th Congress of the ESCRS
Reference: PP14.10 | Type: Case report | DOI: 10.82333/146p-6f51
Authors: Artemis Matsou** 1 , Hanbin Lee 1 , Ahmed Abdelmaksoud 1 , Mohamed Elalfy 1 , Samer Hamada 1
1Corneoplastic Unit,Queen Victoria Hospital,East Grinstead,United Kingdom
To report an atypical case of possible peripheral hypertrophic subepithelial corneal degeneration (PHSCD) in a 57 year old male patient following pterygium excision with conjunctival autograft.
A 57 year old male patient presented with a right eye symptomatic and clinically typical nasal pterygium, for which he was treated with pterygium excision and conjunctival autograft uneventfully. Three years after his surgery, he presented with reduced visual acuity (RE 6/60 unaided) and monocular double vision. There were none of the conjunctival changes of a typical pterygium and no signs of active ocular surface inflammation in either eye. Examination revealed right eye subepithelial corneal scarring in the nasal and temporal cornea leaving a minimum clear central cornea of 2mm. The bulbar conjunctiva was completely normal. Due to visual axis involvement and associated high irregular astigmatism, a femtosecond superficial keratectomy of 80microns depth was performed with good outcome. One year later, the subepithelial scarring recurred in the same pattern but more dense, causing reduced visual acuity again. The lesion followed a clear plane on anterior segment OCT and a manual superficial keratectomy was conducted with complete removal of the scarred tissue. Histopathological examination revealed non-specific fibrotic changes. Following that, a year later the lesion recurred for a third time following the same subepithelial plane. Phototherapeutic combined with photorefractive keratectomy was performed with use of mitomycin C and a masking agent with good outcome. The patient remained asymptomatic since.